CPC A61K 38/37 (2013.01) [A61P 7/04 (2018.01); C07K 14/745 (2013.01); C07K 14/755 (2013.01); C12N 15/62 (2013.01); A61K 38/00 (2013.01); C07K 2319/00 (2013.01); C07K 2319/02 (2013.01); C07K 2319/20 (2013.01); C07K 2319/31 (2013.01); C07K 2319/35 (2013.01)] | 25 Claims |
1. A recombinant glycosylated polypeptide comprising an amino acid sequence identical to a naturally-occurring human protein or fragment thereof, wherein said recombinant glycosylated polypeptide contains one or more clusters of O-glycosylation sites, wherein a cluster contains at least three O-glycosylation sites and at least one O-glycosylation site in four amino acids; wherein the total number of O-glycosylation sites and the combined number of sialylated core 2 and extended core 1 O-glycans of the recombinant glycosylated polypeptide is higher than the total number of O-glycosylation sites and the combined number of sialylated core 2 and extended core 1 O-glycans of the naturally-occurring human protein or fragment thereof; and wherein the recombinant glycosylated polypeptide shows an increased binding affinity to one or more SIGLECs selected from SIG-5, SIG-7, SIG-8, and SIG-9, compared to the naturally-occurring human protein or fragment thereof.
|